// App-Quantinova.ai

: Spatial-Temporal Multiomic Analysis of Tumor-Immune Interactions in Patients with AML Receiving Pembrolizumab and Decitabine

Researchers

Presenter

  • Gege Gui

Principal Investigators

  • Abigail Wong-Rolle

  • Laura W. Dillon

  • Meghali Goswami

  • Eddie Martin

  • Prajan Divakar

  • Jason Reeves

  • Katherine R. Calvo

  • Kasper D. Hansen

  • Christopher S. Hourigan

  • Chen Zhao

Medical Centers

  • Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD

  • Thoracic and GI Malignancies Branch, NCI, Bethesda, MD

  • Hematology Section, Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD

  • Department of Laboratory Medicine, NIH Clinical Center, Bethesda, MD

  • Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

Locations

  • United States

Companies

  • NanoString Technolog

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • T-cell receptor

Drug/Treatment

  • Pembrolizumab

  • Decitabine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A